Search

everythinglearnresearchcommunity

for

Search:↓

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Injecting a peptide-hyaluronic acid mix improved hair growth in men with hair loss and was safe.

Key genes for mink fur have been identified, aiding conservation efforts.

MMP® with minoxidil may improve hair growth in chronic telogen effluvium.

Hair growth can be induced by certain cells found at the base of hair follicles, and these cells may also influence hair development and regeneration.

Researchers discovered new cell types in goat hair follicles that could help understand hair regrowth and human hair loss.

New small molecule drugs could help treat hair loss.

The Gsdma3 gene is essential for normal hair development in mice.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Female pattern hair loss shows similar characteristics in both genders and should be classified by hair loss patterns, not gender.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Eclipta alba extract may help hair grow similarly to Minoxidil.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Etretinate treatment changed hair growth patterns in many patients.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

Genes related to pigmentation, body rhythms, and behavior change during hares' seasonal coat color transition, with a common genetic mechanism in two hare species.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Melatonin affects skin and hair color and protects skin cells, with potential benefits for hair growth and skin health.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Sertraline, an antidepressant, may rarely cause hair loss.

Stem cell treatment improved hair density in female hair loss patient.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.